Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis-Reference-Cited by-同舟云学术

Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis

Published:2017-02-24 Issue:16 Volume:8 Page:26552-26564
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Li Liubing¹,Wang Qian¹,Yang Funing¹²,Wu Chanyuan¹,Chen Si¹³,Wen Xiaoting¹,Liu Chenxi¹,Li Yongzhe¹

Affiliation:

1. Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China

2. Department of Medical Laboratory, The First Hospital of Jilin University, Changchun, China

3. Department of Clinical Laboratory, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble form of the MDA5 protein in human sera;Heliyon;2024-06

2. Clinical importance of anti-Ro52 antibody in polymyositis and dermatomyositis;Modern Rheumatology;2024-05-28

3. Current Biomarker Strategies in Autoimmune Neuromuscular Diseases;Cells;2023-10-15

4. Immune cell profiles of idiopathic inflammatory myopathy patients expressed anti-aminoacyl tRNA synthetase or anti-melanoma differentiation-associated gene 5 autoantibodies;BMC Immunology;2023-09-26

5. Coexistent Relapsing Polychondritis and Clinically Amyopathic Dermatomyositis: A Rare Association of Autoimmune Disorders;Case Reports in Rheumatology;2023-04-11